<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03528811</url>
  </required_header>
  <id_info>
    <org_study_id>4250085-34</org_study_id>
    <nct_id>NCT03528811</nct_id>
  </id_info>
  <brief_title>Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes</brief_title>
  <official_title>Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of the present study was to evaluate the microcirculation of peripheral vascular
      disease in diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">July 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coincidence rate of &quot;5 points test of Tongji university&quot;</measure>
    <time_frame>12 months</time_frame>
    <description>The primary study endpoint was that the coincidence rate of evaluating the microcirculation by the newly-established &quot;5 points test of Tongji university&quot; attains over 95% before and after operations as assessed by digital substraction angiography (DSA).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Peripheral Vascular Disease in Diabetes</condition>
  <arm_group>
    <arm_group_label>Five points test of Tongji university</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>We established the evaluatation and follow-up system of diabetes vascular disease based on the method called &quot;Five points test of Tongji university&quot; .</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Five points test of Tongji university</intervention_name>
    <description>In each group, we will evaluate the microcirculation of diabetic foot using the newly-established &quot;Five points test of Tongji university&quot; before or after the operation, and then compare the temperature of the five points with the other data.</description>
    <arm_group_label>Five points test of Tongji university</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.Patients with Peripheral vascular disease with or without diabetes. 2.Rutherford
             class 2-6. 3.Target lesions with a diameter reduction of at least 50% on angiography,
             and without past history of any intervention.

             4.Target vessel with 2.0--10.0mm in diameter and having a lesion of about 4cm-20cm in
             length.

             5.Written informed consent signed by the patients or representatives

        Exclusion Criteria:

          -  1.Previous bypass surgery or stent placement at the ipsilateral lower limb 2.History
             of intolerance to antiplatelet therapy, heparin, or contrast media. 3.Bleeding
             diathesis; 4.Active systemic bacterial infection; 5.Severely impaired renal function
             (serum creatinine level &gt; 2.5 mg/dL. Expected survival time of less than 24 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xue Li, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maoquan Li, Ph.D</last_name>
    <phone>02166313506</phone>
    <email>cjr.limaoquan@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital, Tong ji University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mao Q Li, Ph.D</last_name>
      <phone>02166313506</phone>
      <email>cjr.limaoquan@vip.163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2018</study_first_submitted>
  <study_first_submitted_qc>May 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2018</study_first_posted>
  <last_update_submitted>May 6, 2018</last_update_submitted>
  <last_update_submitted_qc>May 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Maoquan Li</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Peripheral Vascular Disease</keyword>
  <keyword>Microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

